Stocks · Health care · Pharmaceutical Preparations

PUMA BIOTECHNOLOGY, INC.

PBYI Clue Score62
United States Fiscal year ends December CIK 0001401667 Results filed 5 Nov 2026

What the insiders did Net selling

By person

20 insiders · 292 transactions
71.1×

Alan H. Auerbach holds 71.1 times base salary in stock. $66.25M of shares against $931.33K in salary for 2025.

Salary from the company's own proxy. The shares are what Alan H. Auerbach last reported holding, valued at $9.12, the price Common Stock was last bought or sold at on the open market here, on 14 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Adage Capital Partners Gp, L.l.c. entity
10% owner
—
$157.55M (30)
−$157.55M
3,696,580
7.16%
$33.72M
−35.0%
Alan H Auerbach
President and CEO
—
$5.90M (70)
−$5.90M
7,261,671
14.07%
$66.25M
+73.3%
Richard Paul Bryce
See Remarks
—
$4.49M (40) scheduled
−$4.49M
121,662
0.2357%
$1.11M
+145.6%
Adrian Senderowicz
Director
—
$1.10M (7)
−$1.10M
27,000
0.0523%
$246.32K
—
Troy Edward Wilson
Director
—
$959.24K (8)
−$959.24K
55,300
0.1071%
$504.50K
+6,044%
Jay M Moyes
Director
—
$919.63K (8)
−$919.63K
58,322
0.1130%
$532.07K
—
Alessandra Cesano
Director
—
$699.21K (3) scheduled
−$699.21K
56,700
0.1098%
$517.27K
—
Steven Lo
Chief Commercial Officer
—
$604.10K (6)
−$604.10K
19,557
0.0379%
$178.42K
−37.9%
Douglas M Hunt
See Remarks
—
$485.11K (39) scheduled
−$485.11K
196,841
0.3813%
$1.80M
+4,274%
Maximo F Nougues
Chief Financial Officer
—
$483.39K (35) scheduled
−$483.39K
230,637
0.4468%
$2.10M
—
Charles R Eyler
See Remarks
—
$460.97K (10)
−$460.97K
31,957
0.0619%
$291.54K
+248.8%
Michael Patrick Miller
Director
—
$456.71K (6)
−$456.71K
81,000
0.1569%
$738.96K
—
Jeffrey Jerome Ludwig
Chief Commercial Officer
—
$215.25K (8) scheduled
−$215.25K
156,792
0.3037%
$1.43M
—
Allison Dorval
Director
—
$194.65K (4) scheduled
−$194.65K
90,780
0.1759%
$828.19K
—
Brian M Stuglik
Director
—
$188.47K (5) scheduled
−$188.47K
113,858
0.2206%
$1.04M
—
Robert Charnas
See Remarks
—
$171.96K (3)
−$171.96K
26,453
0.0512%
$241.33K
−16.7%
Ann Calby Miller
Director
—
$147.16K (1)
−$147.16K
40,732
0.0789%
$371.60K
—
Alvin F Wong
Chief Scientific Officer
—
$88.52K (9) scheduled
−$88.52K
141,241
0.2736%
$1.29M
+672.5%
Frank Zavrl
Director
—
—
—
960,069
1.86%
$8.76M
+5.6%
Hugh O'Dowd
Director
—
—
—
25,748
0.0499%
$234.90K
—